By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Endonovo Therapeutics 

Los Angeles   California    U.S.A.
Phone: n/a Fax: n/a



Company News
Endonovo Awarded Preliminary Injunction Against Kodiak Capital et al 6/24/2016 11:16:26 AM
Endonovo Provides Update On Variable Convertible Notes 6/16/2016 1:02:30 PM
Endonovo To Present At The 2016 Marcum Microcap Conference In New York 5/6/2016 9:59:23 AM
Endonovo To Present At The SeeThruEquity 5th Annual Microcap Investor Conference in New York 4/14/2016 11:43:49 AM
Endonovo Receives USPTO Notice Of Allowance For Patent Covering Production Of Biomolecules From Adult Stem Cells 3/31/2016 11:21:22 AM
Endonovo Provides Corporate Update And 2016 Outlook 3/15/2016 11:03:18 AM
Endonovo Buys Back Convertible Note From Lender Avoiding Any Immediate Dilution 12/14/2015 1:36:24 PM
Endonovo Developing Next-Generation Cell Therapy For Acute and Chronic Graft-Versus-Host Disease Using Cell-Enhancing Cytotronics Platform 11/3/2015 10:54:48 AM
Endonovo Files Patent Application on Cell Therapy Created Using Its Proprietary Cell-Enhancing Cytotronics Platform 10/27/2015 9:27:07 AM
Endonovo Therapeutics Announces Immunotronic And Cytotronic Platforms 10/7/2015 1:19:22 PM